Suchergebnisse - Postma, DS

Reply von Van Der Schans, CP, Piers, DA, Postma, DS

Volltext

Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day von Pedersen SE, Prasad N, Goehring UM, Andersson H, Postma DS

Volltext

Genetic variation in <it>TIMP1 </it>but not <it>MMPs </it>predict excess FEV₁decline in two general population-based cohorts von Blokstra A, Siedlinski M, Postma DS, van Diemen CC, Smit HA, Boezen HM

Volltext

Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease von van der Vaart H, Postma DS, Grevink R, Roemer W, ten Hacken NHT

Volltext

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations von Calverley PM, Postma DS, Anzueto AR, Make BJ, Eriksson G, Peterson S, Jenkins CR

Volltext

A score to predict short-term risk of COPD exacerbations (SCOPEX) von Make BJ, Eriksson G, Calverley PM, Jenkins CR, Postma DS, Peterson S, Östlund O, Anzueto A

Volltext

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials von Eriksson G, Calverley PM, Jenkins CR, Anzueto AR, Make BJ, Lindberg M, Fagerås M, Postma DS

Volltext

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD von Calverley PM, Eriksson G, Jenkins CR, Anzueto AR, Make BJ, Persson A, Fagerås M, Postma DS

Volltext

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD von Postma DS, Roche N, Colice G, Israel E, Martin RJ, van Aalderen WMC, Grigg J, Burden A, Hillyer EV, von Ziegenweidt J, Gopalan G, Price D

Volltext